MP Diagnostics

BloodScreen ELISA Range

Complete Blood Screening, No Missing Pieces

Broadest
Range

Superior
Performance

Convenience
Of Use

Identifying your missing piece

Every year, lack of effective blood screening results in up to 16 million new infections with Hepatitis B,
5 million new infections with Hepatitis C, and 160,000 cases of HIV infection.
The transmission of infection through transfusion of infected blood and blood products can be easily prevented
through screening of blood.
WHO recommends that, at a minimum, blood be screened for HIV, Hepatitis B, Hepatitis C, and Syphilis.
Improving blood safety worldwide. Lancet 2007;370:361.

Solving the diagnostic puzzle

Early detection helps to preserve the quality of life.
Infectious diseases are leading cause of mortality and morbidity. Diseases such as HIV, Hepatitis and sexually
transmitted diseases significantly disable millions, diminishing their quality of life.
Early diagnosis helps prevent the spread of infectious agents. It allows patients to receive early treatment,
preserving their quality of life.

An assembly of Blood Screening ELISAs

MP
P Diagnostics BloodScreen ELISA The complete piece to your puzzle.
Our comprehensive range of blood screening kits ensures the safety of your blood supply. Each kit is highly
sensitive and specific, thus giving you an accurate diagnosis in the shortest time possible.

MPD Blood Screening Solutions... No more missing pieces

Comprehensive range to
address your blood screening
needs

Highly sensitive and

specific for reliable and
accurate results

Ready-to-use reagents reduce

preparation time

Open system kits for high

flexibility

Single incubation temperature

reduces assay variation

Short assay time gives fast

test results

Syphilis Blood Screening Solution

12 million people worldwide are diagnosed with Syphilis annually, affecting 2 million
pregnancies and causing over 157,000 deaths
Antibody to Treponema pallidum is the first serological marker of syphilis infection and
screening for it is recommended as minimum standard for blood safety
WHO website/Screening donated blood for transfusion-transmissible infections: recommendations, 2010.

MPD TP ELISA 4.0

For the detection of Treponema pallidum antibodies in human plasma or serum
Utilises
recombinant
antigens
p47, p17 & p15

Detects all
stages of Syphilis

Performs better
than RPR & TPPA
tests

Sensitivity
99.52%

Specificity
99.95%

HIV Blood Screening Solution

HIV is a global pandemic that has infected over 65 million people and caused 25 million
deaths since 1981
Screening for HIV antibody is recommended as minimum standard for blood safety and
specific detection of antibodies to both HIV-1 and HIV-2 is essential
WHO website/Screening donated blood for transfusion-transmissible infections: recommendations, 2010.

MPD HIV-1/2 ELISA 4.0 / HIV Ag/Ab Combo ELISA 4.0

For the detection of HIV-1/2 antibodies OR HIV-1/2 antibodies or/and antigens in human serum or plasma
Available in
3rd and 4th
generation assays

Simultaneous
detection of
multiple
antibody types

Utilises
recombinant
antigens gp41,
gp120 & gp36

Sensitivity
100% (Ab)
100pg/ml (Ag)

Specificity
>99.75%

HCV Blood Screening Solution

It is estimated that 3-4 million people are infected with HCV each year and 130-170 million
are chronic carriers
HCV antibody appears in response to HCV infection and screening for it is recommended as
minimum standard for blood safety
WHO website/Screening donated blood for transfusion-transmissible infections: recommendations, 2010.

MPD HCV ELISA 3.0

For the detection of HCV antibodies in human serum or plasma
Shorter
window period
with 3rd
generation assay

Detects all
6 genotypes
of HCV

Utilises
recombinant
antigens Core,
NS3, NS4 & NS5

Sensitivity
99.79%

Specificity
99.55%

MP Diagnostics
BloodScreen ELISA Range

HBV Blood Screening Solutions

About 2 billion people worldwide have been infected with HBV and an estimated 600,000
people die each year due to the acute or chronic consequences of Hepatitis B
HBsAg is the first serological marker of HBV infection and screening for it is recommended
as minimum standard for blood safety
WHO website/Screening donated blood for transfusion-transmissible infections: recommendations, 2010.

MPD HBV ELISA Range

For the detection of different Hepatitis B Virus serological markers in human serum or plasma
Aids in monitoring
and management
of disease

Detects all
subtypes of HBV

Detects Hepatitis B Virus Surface Antigen (HBsAg), the most

important protein of the envelope of HBV

MPD HBeAg ELISA 4.0

MPD Anti-HBs ELISA 4.0

HIV Ag/Ab Combo ELISA 4.0

HCV ELISA 3.0
HBsAg ELISA 4.0

Detects antibodies to Hepatitis B Virus Core Antigen (anti-HBc),

a marker of acute, chronic or resolved HBV infection

MPD HBc IgM ELISA 4.0

Detects antibodies to Hepatitis B Virus Surface Antigen

(anti-HBs), a marker for recovery from HBV infection and
monitoring of recipients of vaccination

HIV-1/2 ELISA 4.0

Detects antibodies to Hepatitis B Virus e Antigen (anti-HBe), a

clinical sign of recovery from HBV infection

MPD Anti-HBc ELISA 4.0

Detects Hepatitis B Virus e Antigen (HBeAg), a marker

associated with virus replication and high degree of infectivity

TP ELISA 4.0

Cat No.

Detects IgM antibodies to Hepatitis B Virus Core Antigen (HBc

IgM), indication of an ongoing or recent HBV infection

Order Information
Pack Size
Product
(Tests/Kit)

23560-096
23560-480
23031-096
23031-480
23041-096
23041-480
23131-096
23131-480
23471-096
23471-480

96
480
96
480
96
480
96
480
96
480

HBeAg ELISA 4.0

Anti-HBc ELISA 4.0
HBc IgM ELISA 4.0
Anti-HBe ELISA 4.0
Anti-HBs ELISA 4.0

MP Biomedicals Asia Pacific

MP Biomedicals
Asia Pacific Pte Ltd, HQ

Specificity
>99.8%

MPD Anti-HBe ELISA 4.0

MPD HBsAg ELISA 4.0

Product

Sensitivity
>99.7%

Cat No.

Pack Size
(Tests/Kit)

23201-048
23201-096
23181-048
23181-096
23191-048
23191-096
23231-048
23231-096
23241-048
23241-096

48
96
48
96
48
96
48
96
48
96

MP Biomedicals Worldwide

MP Biomedicals Europe

MP Biomedicals Shanghai Pte Ltd

MP Biomedicals Japan K. K.

MP Biomedicals India Pvt Ltd

MP Biomedicals Australasia Pty Ltd

MP Biomedicals LLC, HQ

MP Biomedicals SAS, HQ

2 Pioneer Place
Singapore 627885

Room 505, Metro Bank Plaza

No.1160 West Yanan Road
Changning District, Shanghai 200052

Pineland Building 3-11

Nihonbashi-Ohdenmacho
Chuo-ku, Tokyo 103-0011

312, Jolly Bhavan No. 2

New Marines Line
Mumbai 400020

P.O.Box 187
2/29 Bearing Road
Seven Hills, NSW 2147

3 Hutton Center Drive

Suite 100, Santa Ana
California 92702

Parc dInnovation
BP 50067
67402 Illkirch Cedex
France

Tel : (65) 6775 0008

Fax : (65) 6774 6146

Tel : (86) 21 6281 5005

Fax : (86) 21 6281 5663

Tel : (81) 3 3808 2102

Fax : (81) 3 3808 2401

Tel : (91) 22 22631257/58

Fax : (91) 22 22631259

Tel : (61) 2 9838 7422

Fax : (61) 2 9838 7390

Email: enquiry_ap@mpbio.com

Email: support.china@mpbio.com

Email: mpbioj@wg8.so-net.ne.jp

Email: sales.india@mpbio.com

Email: aus.cs@mpbio.com

Tel : (1949) 833 2500

Toll Free (USA): 1 800 888 7008
Fax : (1949) 421 2539
Email: sales@mpbio.com

Tel : (33) 388 67 4607

Fax : (33) 388 67 5420
Email: custserv.eur@mpbio.com

CCC0611-0

Serological
detection of HBV
antigens or
antibodies